European Archives - Page 223 of 1217 - European Medical Journal

NGS Tools Show Promise in Predicting AMR in Pneumococci

Both Pathogenwatch and AREScloud demonstrated strong performance in predicting antimicrobial resistance in Streptococcus pneumoniae isolates.

New Model Predicts Crohn’s Disease Risk in Relatives

A new integrative risk score predicts the risk of Crohn’s disease in healthy first-degree relatives of individuals with the disease.

Skin Symptom Impact on Life Quality in Graft-Versus-Host Disease

Cutaneous chronic graft-versus-host disease impairs quality of life, affecting social, psychological, physical functioning, and health perceptions.

Checklist

Major changes to product information leaflets to hit Europe

The European pharma sector is on the brink of regulatory and operational updates with new papers from pharmaceutical associations

Genetic Discovery Unlocks Epilepsy Treatments with Repurposed Cancer Drugs

Discovery of DYRK1A and EGFR mutations advances personalised epilepsy care, offering diagnostic biomarkers and repurposed drug opportunities.

Urinary Microbiome of Patients with Spina Bifida Influences UTI Risk

New research provides valuable insights into the urinary and intestinal microbiomes of individuals with spina bifida, a condition associated with an increased risk for UTIs.

Innovative Valve Treatment Shows Potential for Patients With Emphysema

Combined valve implantation in the right upper and middle lobes shows promise for severe emphysema, with significant benefits for heterogeneous cases.

High-Risk Women with BRCA Mutations Often Denied Breast MRI

Novel research has shown that women are frequently denied MRI scans, despite usual recommendations.

5-Year Outcomes of Valve Type and Anaesthesia Strategy for TAVR

SEV and BEV valves with CS or GA yield similar TAVR outcomes; CS lowers mortality and SEVs reduce stroke risk.

mRNA-Based T-Cell Therapy Offers Safer, More Affordable Cancer Treatment

A new study has introduced an innovative approach to CAR-T therapy that could address some of the current challenges in cancer treatment…